Metabolomic Fingerprints of Medical Therapy Versus Bariatric Surgery in Patients With Obesity and Type 2 Diabetes: The STAMPEDE Trial
We identified a novel metabolomic fingerprint characterizing the longer-term adaptations to MT, RYGB, and SG. Notably, the metabolomic profiles of RYGB and SG procedures were distinct, indicating equivalent weight loss may be achieved by divergent effects on metabolism.
Authors
- Adithya Hari (ORCID: https://orcid.org/0009-0004-1511-0648)
- Christopher L. Axelrod (ORCID: https://orcid.org/0000-0002-1444-8557)
- John P. Kirwan (ORCID: https://orcid.org/0000-0001-7321-9917)
- Sangeeta R. Kashyap (ORCID: https://orcid.org/0000-0002-7489-6650)
- Wagner S. Dantas (ORCID: https://orcid.org/0000-0003-4561-4930)
- Philip R. Schauer (ORCID: https://orcid.org/0000-0002-4029-7537)
Institutions
- Pennington Biomedical Research Center (US)
- Cleveland Clinic (US)
- Cleveland Clinic Lerner College of Medicine (US)
Publication Details
- Journal
- Diabetes Care
- Published
- 2024-09-23
- DOI
- https://doi.org/10.2337/dc24-0859
- Citations
- 12
- Primary Topic
- Diet and metabolism studies
- Type
- article
- Field-Weighted Citation Impact
- 3.92
Funders
- LifeScan
- Cleveland Clinic
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases
- Ethicon Endo-Surgery